Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caspases are a family of cysteine-dependent aspartate-specific proteases that play essential roles in programmed cell death (apoptosis) and inflammation. They are synthesized as inactive zymogens (procaspases) and activated by proteolytic cleavage. Caspases are classified into initiator, effector, and inflammatory caspases, each with distinct roles in apoptotic and inflammatory pathways. They recognize specific tetrapeptide motifs in substrates and their activity is tightly regulated by endogenous inhibitors and regulatory feedback mechanisms. Caspase dysregulation is implicated in various diseases, including cancer, neurodegeneration, and immune disorders.
Proteolytic cleavage of target proteins after aspartate residues leading to apoptosis or inflammation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caspase Family Proteins (Caspases).